0001486189-23-000032.txt : 20231004
0001486189-23-000032.hdr.sgml : 20231004
20231004112708
ACCESSION NUMBER: 0001486189-23-000032
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230930
FILED AS OF DATE: 20231004
DATE AS OF CHANGE: 20231004
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sim Brandon
CENTRAL INDEX KEY: 0001813532
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41097
FILM NUMBER: 231307096
MAIL ADDRESS:
STREET 1: C/O APOLLO MEDICAL HOLDINGS, INC.
STREET 2: 1668 S. GARFIELD AVENUE, 3RD FLOOR
CITY: ALHAMBRA
STATE: CA
ZIP: 91801
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cardio Diagnostics Holdings, Inc.
CENTRAL INDEX KEY: 0001870144
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 870925574
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 311 W. SUPERIOR STREET
STREET 2: SUITE 444
CITY: CHICAGO
STATE: IL
ZIP: 60645
BUSINESS PHONE: 855-226-9991
MAIL ADDRESS:
STREET 1: 311 W. SUPERIOR STREET
STREET 2: SUITE 444
CITY: CHICAGO
STATE: IL
ZIP: 60645
FORMER COMPANY:
FORMER CONFORMED NAME: Mana Capital Acquisition Corp.
DATE OF NAME CHANGE: 20210629
4/A
1
primary_doc.xml
PRIMARY DOCUMENT
X0508
4/A
2023-09-30
2023-10-03
0
0001870144
Cardio Diagnostics Holdings, Inc.
CDIO
0001813532
Sim Brandon
C/O CARDIO DIAGNOSTICS HOLDINGS INC.
311 W. SUPERIOR ST. SUITE 444
CHICAGO
IL
60654
1
0
0
0
0
Common Stock
2023-09-30
4
M
0
36765
0.34
A
57773
D
Restricted Stock Units
0
2023-09-30
4
M
0
12500
0
D
2023-09-30
2023-12-31
Common Stock
12500
12500
D
Represents the settlement of restricted stock units (RSUs) that vested on September 30, 2023 through the issuance of shares of Common Stock.
Each RSU is the economic equivalent of one share of Cardio Diagnostics Holdings, Inc. common stock. On September 30, 2023, $12,500 in value of RSUs vested and were settled at the price of $0.34, which was the closing price of the Company Common Stock on the vesting date. The settlement shares are reflected in Table I.
On June 19, 2023, the reporting person was awarded $50,000 in value of RSUs, of which $12,500 in value vested on September 30, 2023. Subject to continued service with the Issuer on the vesting date, the remaining $12,500 in value of RSUs will vest on December 31, 2023, based on the closing price of the Issuers common stock on the vesting date.
The RSUs were granted pursuant to the Issuers 2022 Equity Incentive Plan
/s/ Elisa Luqman as attorney-in-fact for Brandon Sim
2023-10-04